Clinical Trial Site

Caen 30001

3 studies enrolling now · 5 studies all time

What they study most

ANCA-Associated Vasculitis, Advanced Breast Cancer, Atypical Hemolytic-Uremic Syndrome, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Metastatic Breast Cancer, Prostate Cancer Metastatic

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer — Completed
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed